SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-099499
Filing Date
2020-04-06
Accepted
2020-04-06 16:11:03
Documents
4
Period of Report
2020-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d909334d8k.htm 8-K 29291
2 EX-3.1 d909334dex31.htm EX-3.1 72580
3 EX-10.1 d909334dex101.htm EX-10.1 109511
4 GRAPHIC g909334g41r30.jpg GRAPHIC 4224
  Complete submission text file 0001193125-20-099499.txt   218797
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 20777104
SIC: 8731 Services-Commercial Physical & Biological Research